Publications by authors named "Krista Heinolainen"

4Publications

VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.

Circ Res 2017 Apr 15;120(9):1414-1425. Epub 2017 Mar 15.

From the Wihuri Research Institute and Translational Cancer Biology Research Program, Biomedicum Helsinki, University of Helsinki, Finland (K.H., S.K., G.D'A., T.T., K.A., G.Z.); Biocenter Oulu and Department of Pathology, University of Oulu and Oulu University Hospital, Finland (R.S.); and Oulu Center for Cell-Matrix Research, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Finland (L.E.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.116.310477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959003PMC
April 2017

Critical requirement of VEGF-C in transition to fetal erythropoiesis.

Blood 2016 08 24;128(5):710-20. Epub 2016 Jun 24.

Wihuri Research Institute and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-12-687970DOI Listing
August 2016

VEGFR3 does not sustain retinal angiogenesis without VEGFR2.

Proc Natl Acad Sci U S A 2015 Jan 5;112(3):761-6. Epub 2015 Jan 5.

Wihuri Research Institute and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FIN-00014 Helsinki, Finland;

View Article

Download full-text PDF

Source
http://www.pnas.org/content/112/3/761.full.pdf
Web Search
http://www.pnas.org/lookup/doi/10.1073/pnas.1423278112
Publisher Site
http://dx.doi.org/10.1073/pnas.1423278112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311859PMC
January 2015

VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.

Nat Cell Biol 2011 Sep 11;13(10):1202-13. Epub 2011 Sep 11.

Molecular/Cancer Biology Laboratory, Institute for Molecular Medicine Finland, Research Programs Unit and Department of Pathology, Haartman Institute, Biomedicum Helsinki, PO Box 63 (Haartmaninkatu 8), 00014 University of Helsinki, Finland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261765PMC
http://dx.doi.org/10.1038/ncb2331DOI Listing
September 2011